Upon PMA/ionomycin stimulation higher numbers of IFN-γ, TNF-α and IL-21 secreting T cells were detected in MM patients under lenalidomide maintenance treatment compared to MM patients that did not receive lenalidomide [15]. This evidence concerns the gene IFNG and Miyoshi myopathy.